Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI.
Biomarkers
Embolism
Magnetic resonance imaging
Stroke
Thrombosis
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
20
07
2018
accepted:
02
10
2018
revised:
17
09
2018
pubmed:
14
11
2018
medline:
29
5
2019
entrez:
14
11
2018
Statut:
ppublish
Résumé
We aimed to determine in the "THRACE" trial, the clinical and MRI technical parameters associated with the two-layered susceptibility vessel sign (TL-SVS) and the overestimation ratio (overR). Patients with pre-treatment brain gradient echo (GRE) sequence and an etiological work-up were identified. Two readers reviewed TL-SVS, i.e., a SVS with a linear low-intense signal core surrounded by a higher intensity and measured the overR as the width of SVS divided by the width of the artery. Binomial and ordinal logistic regression respectively tested the association between TL-SVS and quartiles of overR with patient characteristics, cardioembolic stroke (CES), time from onset to imaging, and GRE sequence parameters (inter slice gap, slice thickness, echo time, flip angle, voxel size, and field strength). Among 258 included patients, 102 patients were examined by 3 Tesla MRI and 156 by 1.5 Tesla MRI. Intra- and inter-reader agreements for quartiles of overR and TL-SVS were good to excellent. The median overR was 1.59 (IQR, 1.30 to 1.86). TL-SVS was present in 101 patients (39.2%, 95%CI, 33.1 to 45.1%). In multivariate analysis, only CES was associated with overR quartiles (OR, 1.83; 95%CI, 1.11 to 2.99), and every 60 min increase from onset to MRI time was associated with TL-SVS (OR, 1.72; 95%CI, 1.10 to 2.67). MRI technical parameters were statistically associated with neither overR nor TL-SVS. Independent of GRE sequence parameters, an increased overR was associated to CES, while the TL-SVS is independently related to a longer time from onset to MRI. • An imaging biomarker would be useful to predict the etiology of stroke in order to adapt secondary prevention of stroke. • The two-layered susceptibility vessel sign and the overestimation ratio are paramagnetic effect derived markers that vary according to the MRI machines and sequence parameters. • Independent of sequence parameters, an increased overestimation ratio was associated to cardioembolic stroke, while the two-layered susceptibility vessel sign is independently related to a longer time from onset to MRI.
Identifiants
pubmed: 30421018
doi: 10.1007/s00330-018-5835-y
pii: 10.1007/s00330-018-5835-y
doi:
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
2624-2631Subventions
Organisme : This study was funded by the French Ministry for Health as part of its 2009 STIC programme for the support of costly innovations (grant number 2009 A00753-54). The trial steering committee attests to the integrity of the trial, the fidelity of this report to the study protocol, and the completeness and accuracy of the reported data.
ID : This study was funded by the French Ministry for Health as part of its 2009 STIC programme for the support of costly innovations (grant number 2009 A00753-54). The trial steering committee attests to the integrity of the trial, the fidelity of this report to the study protocol, and the completeness and accuracy of the reported data.
Références
J Neurointerv Surg. 2017 Jun;9(6):529-534
pubmed: 27166383
J Neuroradiol. 2015 Apr;42(2):86-92
pubmed: 24560545
PLoS One. 2014 Feb 11;9(2):e88882
pubmed: 24523944
Cerebrovasc Dis. 2008;25(5):457-507
pubmed: 18477843
J Stroke. 2016 Jan;18(1):73-9
pubmed: 26846759
Cerebrovasc Dis Extra. 2013 Sep 24;3(1):111-20
pubmed: 24163686
Clin Neuroradiol. 2016 Jun;26(2):189-97
pubmed: 25261075
AJNR Am J Neuroradiol. 2015 Dec;36(12):2346-53
pubmed: 26316570
ASAIO J. 2009 Jan-Feb;55(1):33-40
pubmed: 19092656
J Neurointerv Surg. 2016 Oct;8(10):1001-5
pubmed: 26408028
AJNR Am J Neuroradiol. 2015 Jul;36(7):1266-71
pubmed: 25814657
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Stroke. 2013 Jun;44(6):1647-51
pubmed: 23640823
J Neuroimaging. 2017 Nov;27(6):577-582
pubmed: 28771893
Stroke. 2015 Jan;46(1):269-71
pubmed: 25477219
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e323-31
pubmed: 23379980
AJNR Am J Neuroradiol. 2005 Mar;26(3):618-24
pubmed: 15764589
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):910-8
pubmed: 23273713
Stroke. 2006 Aug;37(8):2086-93
pubmed: 16794209
PLoS One. 2013 Oct 11;8(10):e76727
pubmed: 24146915
Eur J Neurol. 2016 Apr;23(4):737-43
pubmed: 26706832
Stroke. 2011 May;42(5):1237-43
pubmed: 21393591
Forensic Sci Int. 2010 Feb 25;195(1-3):143-7
pubmed: 20060249
Eur J Vasc Endovasc Surg. 2012 Nov;44(5):491-7
pubmed: 22975154
J Neuroradiol. 2012 May;39(2):71-86
pubmed: 22342939
Stroke. 2001 May;32(5):1091-8
pubmed: 11340215
Eur J Neurol. 2015 Jun;22(6):967-72
pubmed: 25786977
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
Stroke. 2005 Nov;36(11):2379-83
pubmed: 16224077
Radiology. 2004 Aug;232(2):466-73
pubmed: 15215546
Clin Neuroradiol. 2019 Dec;29(4):685-692
pubmed: 29947813
Stroke. 2017 Jul;48(7):1993-1996
pubmed: 28536172